Clinical Trial Update: Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial led by Vanderbilt University Medical Center is evaluating low-dose buccal buprenorphine for analgesia and its relative abuse potential.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Pain

Drugs mentioned

• Buprenorphine buccal film (buprenorphine)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Analgesia, Abuse Opioids | Phase 4 | Status: RECRUITING